Chorioamnionitis
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Synonyms and keywords: Intra-amniotic infection; IAI
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
Chorioamnionitis is an inflammatory condition of pregnancy affecting the uterus. It is a bacterial infection of the amniotic sac and the surrounding amniotic fluid. Chorioamnionitis is extremely dangerous to both the mother and fetus and is the most common cause of premature labor. Chorioamnionitis may be classified into several subtypes based on the presentation of the patient, the type of infiltrating cells, anatomical regions infiltrated by neutrophils (stage), and the intensity of inflammation (grade). Chorioamnionitis is an inflammatory condition of fetal membranes which is usually caused by infectious etiology. The opaque appearance of fetal membranes is a characteristic gross pathologic finding of chorioamnionitis. neutrophilic infiltration of the amniotic cavity and/or chorionic plate is the characteristic microscopic finding of chorioamnionitis. Chorioamnionitis may be caused by either bacterial, fungal, or viral microorganisms. Chorioamnionitis must be differentiated from other conditions that cause maternal fever, abdominal pain, or maternal/fetal tachycardia such as epidural-related fever, extrauterine infections, and noninfectious conditions characterized by abdominal pain. Epidural-related fever should be considered in patients with epidural anesthesia who have low grade fever without maternal/fetal tachycardia during the intrapartum period. Extrauterine infections should be considered in patients with fever and abdominal pain. And lastly, noninfectious conditions such as placental abruption should be considered in patients with abdominal pain in the absence of fever. The prevalence of chorioamnionitis was estimated to be approximately 4,000 cases per 100,000 individuals worldwide. Chorioamnionitis more commonly affects individuals < 18 years of age. Gestational age is also a strong predictor of chorioamnionitis with increased prevalence in people who delivered between 21 and 24 weeks of gestation. Male infants are more commonly affected than females. Chorioamnionitis usually affects individuals of Hispanics and Asian/Pacific Islanders. Common risk factors in the development of chorioamnionitis include preterm premature rupture of membranes (PPROM), prematurity, nulliparity, prolonged labor and rupture of membranes, multiple digital vaginal examinations, meconium stained amniotic fluid, internal fetal monitoring, epidural anesthesia, immunocompromised state, maternal behavioral conditions, and infections. Clinical findings associated with chorioamnionitis include maternal fever, uterine tenderness, purulent/foul-smelling amniotic fluid, maternal/fetal tachycardia. Common fetal complications of chorioamnionitis include preterm birth, neonatal sepsis, neurologic complications, respiratory complications. Common maternal complications of chorioamnionitis include maternal sepsis, infections, and labor-related complications (e.g., cesarean section, postpartum hemorrhage, etc.). There is no single diagnostic study of choice for the diagnosis of chorioamnionitis, but chorioamnionitis can be diagnosed based on the clinical presentation, laboratory findings, and/or histopathologic evaluation. The diagnosis of clinical chorioamnionitis is solely based on clinical features include maternal fever, uterine tenderness, maternal/fetal tachycardia, and foul-smelling/purulent amniotic fluid. And the gold standard (test) for the diagnosis of chorioamnionitis is a microbiological culture of the amniotic fluid. Common physical examination findings of chorioamnionitis include fever, abdominal pain, uterine tenderness, tachycardia, and foul-smelling vaginal discharge. Laboratory findings consistent with the diagnosis of chorioamnionitis include maternal leukocytosis, left shift or elevated band count, amniotic fluid findings (e.g., positive amniotic fluid microbiological culture results, bacteria or white blood cells on gram stain, decreased glucose level, elevated IL-6 level, etc.), and histologic findings such as neutrophilic infiltration of chorioamniotic membranes. There are no ECG findings associated with chorioamnionitis. There are no x-ray findings associated with chorioamnionitis. There are no ultrasound findings associated with chorioamnionitis. However, an ultrasound may be helpful in the diagnosis of complications of chorioamnionitis, which include postpartum hemorrhage, pelvic abscesses, endomyometritis, intraventricular hemorrhage, periventricular leukomalacia, respiratory distress syndrome, and bronchopulmonary dysplasia. There are no CT scan findings associated with chorioamnionitis. However, a CT scan may be helpful in the diagnosis of complications of chorioamnionitis, which include pelvic infections and abscesses, adrenal abscesses, and subphrenic abscess. There are no MRI findings associated with chorioamnionitis. However, an MRI may be helpful in the diagnosis of complications of chorioamnionitis, which include spontaneous preterm delivery, white matter injury (WMI), and intraventricular hemorrhage (IVH). Magnetic resonance spectroscopy(MRS) may be helpful for the detection of neuroinflammation during histologic chorioamnionitis. Furthermore, it may suggest a poor neurodevelopmental outcome (e.g. motor development, cognitive development, etc.) in these infants. There are no other diagnostic studies associated with chorioamnionitis. Antimicrobial therapy is indicated among patients with chorioamnionitis. The preferred regimen is a combination of ampicillin and gentamicin. Supportive therapy, such as antipyretics, may also be used. Surgical intervention is not recommended for the management of chorioamnionitis. Effective measures for the primary prevention of chorioamnionitis include induction of labor after 34 weeks of gestation and administration of prophylactic antimicrobial therapy in the presence of preterm premature rupture of membranes (PPROM). There are no established measures for the secondary prevention of chorioamnionitis.
Classification
Chorioamnionitis may be classified into several subtypes based on the presentation of the patient, the type of infiltrating cells, anatomical regions infiltrated by neutrophils (stage), and the intensity of inflammation (grade).
Pathophysiology
Chorioamnionitis is an inflammatory condition of fetal membranes which is usually caused by infectious etiology. The opaque appearance of fetal membranes is a characteristic gross pathologic finding of chorioamnionitis. neutrophilic infiltration of the amniotic cavity and/or chorionic plate is the characteristic microscopic finding of chorioamnionitis.
Causes
Chorioamnionitis may be caused by either bacterial, fungal, or viral microorganisms.
Differentiating Chorioamnionitis from Other Diseases
Chorioamnionitis must be differentiated from other conditions that cause maternal fever, abdominal pain, or maternal/fetal tachycardia such as epidural-related fever, extrauterine infections, and noninfectious conditions characterized by abdominal pain. Epidural-related fever should be considered in patients with epidural anesthesia who have low grade fever without maternal/fetal tachycardia during the intrapartum period. Extrauterine infections should be considered in patients with fever and abdominal pain. And lastly, noninfectious conditions such as placental abruption should be considered in patients with abdominal pain in the absence of fever.
Epidemiology and Demographics
The prevalence of chorioamnionitis was estimated to be approximately 4,000 cases per 100,000 individuals worldwide. Chorioamnionitis more commonly affects individuals < 18 years of age. Gestational age is also a strong predictor of chorioamnionitis with increased prevalence in people who delivered between 21 and 24 weeks of gestation. Male infants are more commonly affected than females. Chorioamnionitis usually affects individuals of Hispanics and Asian/Pacific Islanders.
Risk Factors
Common risk factors in the development of chorioamnionitis include preterm premature rupture of membranes (PPROM), prematurity, nulliparity, prolonged labor and rupture of membranes, multiple digital vaginal examinations, meconium stained amniotic fluid, internal fetal monitoring, epidural anesthesia, immunocompromised state, maternal behavioral conditions, and infections.
Natural History, Complications, and Prognosis
Clinical findings associated with chorioamnionitis include maternal fever, uterine tenderness, purulent/foul-smelling amniotic fluid, maternal/fetal tachycardia. Common fetal complications of chorioamnionitis include preterm birth, neonatal sepsis, neurologic complications, respiratory complications. Common maternal complications of chorioamnionitis include maternal sepsis, infections, and labor-related complications (e.g., cesarean section, postpartum hemorrhage, etc.)
Diagnosis
Diagnostic Study of Choice
There is no single diagnostic study of choice for the diagnosis of chorioamnionitis, but chorioamnionitis can be diagnosed based on the clinical presentation, laboratory findings, and/or histopathologic evaluation. The diagnosis of clinical chorioamnionitis is solely based on clinical features include maternal fever, uterine tenderness, maternal/fetal tachycardia, and foul-smelling/purulent amniotic fluid. And the gold standard (test) for the diagnosis of chorioamnionitis is a microbiological culture of the amniotic fluid.
History and Symptoms
The hallmark of chorioamnionitis is maternal fever. The presence of uterine tenderness, purulent/foul-smelling amniotic fluid, and maternal/fetal tachycardia is suggestive of chorioamnionitis.
Physical Examination
Common physical examination findings of chorioamnionitis include fever, abdominal pain, uterine tenderness, tachycardia, and foul-smelling vaginal discharge.
Laboratory Findings
Laboratory findings consistent with the diagnosis of chorioamnionitis include maternal leukocytosis, left shift or elevated band count, amniotic fluid findings (e.g., positive amniotic fluid microbiological culture results, bacteria or white blood cells on gram stain, decreased glucose level, elevated IL-6 level, etc.), and histologic findings such as neutrophilic infiltration of chorioamniotic membranes.
Electrocardiogram
There are no ECG findings associated with chorioamnionitis.
X-ray
There are no x-ray findings associated with chorioamnionitis.
Echocardiography and Ultrasound
There are no ultrasound findings associated with chorioamnionitis. However, an ultrasound may be helpful in the diagnosis of complications of chorioamnionitis, which include postpartum hemorrhage, pelvic abscesses, endomyometritis, intraventricular hemorrhage, periventricular leukomalacia, respiratory distress syndrome, and bronchopulmonary dysplasia.
CT scan
There are no CT scan findings associated with chorioamnionitis. However, a CT scan may be helpful in the diagnosis of complications of chorioamnionitis, which include pelvic infections and abscesses, adrenal abscesses, and subphrenic abscess.
MRI
There are no MRI findings associated with chorioamnionitis. However, an MRI may be helpful in the diagnosis of complications of chorioamnionitis, which include spontaneous preterm delivery, white matter injury (WMI), and intraventricular hemorrhage (IVH).
Other Imaging Findings
Magnetic resonance spectroscopy(MRS) may be helpful for the detection of neuroinflammation during histologic chorioamnionitis. Furthermore, it may suggest a poor neurodevelopmental outcome (e.g. motor development, cognitive development, etc.) in these infants.
Other Diagnostic Studies
There are no other diagnostic studies associated with chorioamnionitis.
Treatment
Medical Therapy
Antimicrobial therapy is indicated among patients with chorioamnionitis. The preferred regimen is a combination of ampicillin and gentamicin. Supportive therapy, such as antipyretics, may also be used.
Surgery
Surgical intervention is not recommended for the management of chorioamnionitis.
Primary Prevention
Effective measures for the primary prevention of chorioamnionitis include induction of labor after 34 weeks of gestation and administration of prophylactic antimicrobial therapy in the presence of preterm premature rupture of membranes (PPROM).
Secondary Prevention
There are no established measures for the secondary prevention of chorioamnionitis.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
There is limited information about the historical perspective of chorioamnionitis.
Historical Perspective
There is limited information about the historical perspective of chorioamnionitis.
References
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
Chorioamnionitis may be classified into several subtypes based on the presentation of the patient, the type of infiltrating cells, anatomical regions infiltrated by neutrophils (stage), and the intensity of inflammation (grade).
Classification
Chorioamnionitis may be classified into several subtypes based on the presentation of the patient, the type of infiltrating cells, anatomical regions infiltrated by neutrophils (stage), and the intensity of inflammation (grade).[1]
- Chorioamnionitis may be classified according to the absence or presence of clinical signs and laboratory findings into two groups: clinical chorioamnionitis, and subclinical/histologic chorioamnionitis.[2][3]
- Subclinical/histologic chorioamnionitis indicates the inflammation of the chorion, amnion, and placenta in the absence of clinical signs.
- Diagnosis of histologic chorioamnionitis is mainly based on the evaluation of pathology which might be confirmed by the presence of inflammatory cells within the fetal membranes.
- The presence of maternal fever, leukocytosis, maternal/fetal tachycardia, uterine tenderness, foul-smelling amniotic fluid, and preterm rupture of membranes (PROM) indicates the clinical chorioamnionitis.
- Subclinical/histologic chorioamnionitis indicates the inflammation of the chorion, amnion, and placenta in the absence of clinical signs.
- Chorioamnionitis may be classified into acute and chronic forms, depending on the type of infiltrating cells.[4]
- Acute and chronic chorioamnionitis indicate the infiltration of the fetal membranes by PMNs and monocytes, respectively.
- The staging of chorioamnionitis is based on the anatomical regions infiltrated by neutrophils.[1]
- Stage 1 represents the infiltration of chorion or subchorionic space by neutrophils.
- Stage 2 represents the infiltration of chorionic connective tissue and/or amnion or the chorionic plate by neutrophils.
- Stage 3 represents the necrotizing chorioamnionitis, indicates the edema and necrosis of the amniotic epithelium.
- The grading of chorioamnionitis is based on the intensity of inflammation.[1]
- Grade 1, mild to moderate inflammation, represent the infiltration of fetal membranes by small clusters of maternal neutrophils.
- Grade 2, severe inflammation, represents the presence of at least 3 chorionic microabscesses (cluster of neutrophils measuring ≥ 10 x 20 cells) or the presence of neutrophils of ≥ 10 cells in width that involve at least half of the subchorionic fibrin or one cycle around the membrane roll.
- The staging system might be more effective to establish the severity of inflammation than the grading system.[1]
References
- ↑ 1.0 1.1 1.2 1.3 Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM (October 2015). “Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance”. Am J Obstet Gynecol. 213 (4 Suppl): S29–52. doi:10.1016/j.ajog.2015.08.040. PMC 4774647. PMID 26428501.
- ↑ Peng CC, Chang JH, Lin HY, Cheng PJ, Su BH (June 2018). “Intrauterine inflammation, infection, or both (Triple I): A new concept for chorioamnionitis”. Pediatr Neonatol. 59 (3): 231–237. doi:10.1016/j.pedneo.2017.09.001. PMID 29066072.
- ↑ Ericson JE, Laughon MM (March 2015). “Chorioamnionitis: implications for the neonate”. Clin Perinatol. 42 (1): 155–65, ix. doi:10.1016/j.clp.2014.10.011. PMC 4331454. PMID 25678002.
- ↑ Chi BH, Mudenda V, Levy J, Sinkala M, Goldenberg RL, Stringer JS (January 2006). “Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission”. Am J Obstet Gynecol. 194 (1): 174–81. doi:10.1016/j.ajog.2005.06.081. PMID 16389028.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
Chorioamnionitis is an inflammatory condition of fetal membranes which is usually caused by infectious etiology. The opaque appearance of fetal membranes is a characteristic gross pathologic finding of chorioamnionitis. neutrophilic infiltration of the amniotic cavity and/or chorionic plate is the characteristic microscopic finding of chorioamnionitis.
Pathophysiology
Pathogenesis
Chorioamnionitis is an inflammatory condition of fetal membranes which is usually caused by infectious etiology. The pathogenesis can be further divided into 4 categories based on the anatomical route of the introduction of the microorganism:[1]
- Ascending infection might originate from the maternal genital tract (the most common route).
- Vaginal and enteric flora are usually transmitted via the ascending route to the fetal membranes.
- Iatrogenic infection might be caused by invasive procedures (e.g., amniocentesis).
- Maternal infections such as listeria monocytogenes, might infect fetal membranes through the placenta by the hematogenous route.
- In mothers with hepatic or renal diseases, the infection of fetal membranes might be originated by peritoneal infections via the route of fallopian tubes.
Genetics
Genes involved in the pathogenesis of chorioamnionitis include:[2][3]
- Placental IL-6 (minor C allele at the IL6 SNP)
- IL10
- MBL2
- TNFRSF6
- TGFB1
Gross Pathology
On gross pathology, the opaque appearance of fetal membranes is a characteristic finding of chorioamnionitis.[4]
- The presence of opaque fetal membranes might indicate an increased risk of complications of chorioamnionitis in newborns.
Microscopic Pathology
On microscopic histopathological analysis, neutrophilic infiltration of the amniotic cavity and/or neutrophilic infiltration of the chorionic plate are characteristic findings of chorioamnionitis.[5]
- Decidua of the placenta is originated from the mother which might include the neutrophils of mother.
- Chorioamnionic membranes are originated from the fetus which do not include neutrophils in physiologic settings. However, in case of chorioamnionitis, maternal neutrophils migrate into these membranes in the presence of chemotaxis.
References
- ↑ Ericson JE, Laughon MM (March 2015). “Chorioamnionitis: implications for the neonate”. Clin Perinatol. 42 (1): 155–65, ix. doi:10.1016/j.clp.2014.10.011. PMC 4331454. PMID 25678002.
- ↑ Konwar C, Del Gobbo GF, Terry J, Robinson WP (February 2019). “Association of a placental Interleukin-6 genetic variant (rs1800796) with DNA methylation, gene expression and risk of acute chorioamnionitis”. BMC Med Genet. 20 (1): 36. doi:10.1186/s12881-019-0768-0. PMC 6387541. PMID 30795743.
- ↑ Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, McDonald HM (February 2005). “Polymorphisms in immunoregulatory genes and the risk of histologic chorioamnionitis in Caucasoid women: a case control study”. BMC Pregnancy Childbirth. 5 (1): 4. doi:10.1186/1471-2393-5-4. PMC 554771. PMID 15723707.
- ↑ Horikoshi Y, Yaguchi C, Furuta-Isomura N, Itoh T, Kawai K, Oda T, Matsumoto M, Kohmura-Kobayashi Y, Tamura N, Uchida T, Kanayama N, Itoh H (2020). “Gross appearance of the fetal membrane on the placental surface is associated with histological chorioamnionitis and neonatal respiratory disorders”. PLoS One. 15 (11): e0242579. doi:10.1371/journal.pone.0242579. PMC 7704006 Check
|pmc=value (help). PMID 33253176 Check|pmid=value (help). - ↑ Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM (October 2015). “Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance”. Am J Obstet Gynecol. 213 (4 Suppl): S29–52. doi:10.1016/j.ajog.2015.08.040. PMC 4774647. PMID 26428501.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2] ; Luke Rusowicz-Orazem, B.S.
Overview
Causes
Chorioamnionitis may be caused by either bacterial, fungal, or viral microorganisms.[1]
Common Causes
Common bacterial causes of chorioamnionitis include:[1][2]
- Bacteroides sp., especially Prevotella bivius
- Streptococcus agalactiae
- Enterobacteriaceae
- Gardnerella vaginalis
- Mycoplasma pneumoniae
- Chlamydia trachomatis
- Ureaplasma urealyticum
- Fusobacteria sp.
- Escherichia coli
- Viruses (adenoviruses might be associated with histological inflammation.
- Fungi, especially candida, might be the causative agent of chorioamnionitis especially in women who become pregnant while using intrauterine devices.[2]
- Chorioamnionitis due to candida infection is associated by preterm birth and adverse fetal outcomes.[1]
- Trichomonas vaginalis might be the causative microorganism in chorioamnionitis, particularly in young and sexually active patients.
Common causative pathogens could be further divided based on the clinical outcome
- Certain microorganisms which might be seen in patients with spontaneous preterm labor (intact membranes):
- Fusobacterium nucleatum
- Sneathia sanguinegens
- Ureaplasma urealyticum
- Streptococcus mitis
- Gardnerella vaginalis
- Peptostreptococcus
- Leptotrichia amnionii
- Mycoplasma hominis
- Streptococcus agalactiae
- Lactobacillus species
- Bacillus species
- Coagulase-negative Staphylococcus species
- Prevotella species
- Delftia acidovorans
- Neisseria cinerea
- Certain microorganisms which might be seen in patients with clinical chorioamnionitis at term:
- Ureaplasma urealyticum
- Gardnerella vaginalis
- Mycoplasma hominis
- Streptococcus agalactiae
- Lactobacillus species
- Bacteroides species
- Acinetobacter species
- Sneathia
- Streptococcus viridans
- Porphyromonas species
- Veillonella species
- Peptostreptococcus species
- Escherichia coli
- Pseudomonas aeruginosa
- Staphylococcus aureus
- Eubacterium species
- Gram negative bacilli
- Enterococcus species
- Fusobacterium species
- Candida species
- Micrococcus luteus
- Firmicute
- Propionibacterium acnes
- Abiotrophia defective
- Staphylococcus epidermidis
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | No underlying causes |
| Ear Nose Throat | No underlying causes |
| Endocrine | No underlying causes |
| Environmental | No underlying causes |
| Gastroenterologic | Escherichia coli |
| Genetic | No underlying causes |
| Hematologic | Mycoplasma hominis |
| Iatrogenic | No underlying causes |
| Infectious Disease | Adenovirus, Bacteroides , Candida albicans, Chlamydia trachomatis, Endometritis, Enterobacteriaceae, Escherichia coli, Fusobacteria sp., Gardnerella vaginalis , Gram-negative anaerobes , Listeria monocytogenes, Mycoplasma hominis , Prevotella bivius, Streptococcus group b, Streptococcus group a, Ureaplasma urealyticum |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | Mycoplasma hominis |
| Nutritional/Metabolic | No underlying causes |
| Obstetric/Gynecologic | Chlamydia trachomatis, Endometritis, Prolonged labor |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | No underlying causes |
| Sexual | Gardnerella vaginalis |
| Trauma | No underlying causes |
| Urologic | Urinary tract infection |
| Miscellaneous | No underlying causes |
Common Causes in Alphabetical Order
- Adenovirus
- Bacteroides
- Candida albicans
- Chlamydia trachomatis
- Enterobacteriaceae
- Escherichia coli
- Gardnerella vaginalis
- Gram-negative anaerobes
- Group B Streptococcus
- Listeria monocytogenes
- Mycoplasma hominis
- Mycoplasma pneumoniae
- Prevotella bivius
- Ureaplasma urealyticum
References
- ↑ 1.0 1.1 1.2 Fowler JR, Simon LV. PMID 30335284. Missing or empty
|title=(help) - ↑ 2.0 2.1 Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM (October 2015). “Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance”. Am J Obstet Gynecol. 213 (4 Suppl): S29–52. doi:10.1016/j.ajog.2015.08.040. PMC 4774647. PMID 26428501.
Differentiating Chorioamnionitis from other Diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
Chorioamnionitis must be differentiated from other conditions that cause maternal fever, abdominal pain, or maternal/fetal tachycardia such as epidural-related fever, extrauterine infections, and noninfectious conditions characterized by abdominal pain. Epidural-related fever should be considered in patients with epidural anesthesia who have low grade fever without maternal/fetal tachycardia during the intrapartum period. Extrauterine infections should be considered in patients with fever and abdominal pain. And lastly, noninfectious conditions such as placental abruption should be considered in patients with abdominal pain in the absence of fever.
Differentiating Chorioamnionitis From Other Diseases
Chorioamnionitis must be differentiated from other conditions that cause maternal fever, abdominal pain, or maternal/fetal tachycardia such as epidural-related fever, extrauterine infections, and noninfectious conditions characterized by abdominal pain.[1]
- Epidural-related fever should be considered in patients with epidural anesthesia who have low grade fever without maternal/fetal tachycardia during the intrapartum period.
- Extrauterine infections should be considered in patients with fever and abdominal pain. Extrauterine infections that must be differentiated from chorioamnionitis include:
- Appendicitis
- Pneumonia
- Influenza
- Pyelonephritis and other urinary tract infections
- Noninfectious conditions should be considered in patients with abdominal pain in the absence of fever. Noninfectious conditions that must be differentiated from chorioamnionitis include:
- Thrombophlebitis
- Placental abruption
- Colitis
- Connective tissue disorders
- Round ligament pain
Chorioamnionitis, must be differentiated from other diseases that may cause, fever, abdominal pain, and maternal/fetal tachycardia. The table below, summarizes the differential diagnosis for chorioamnionitis:
| Disease | Findings |
|---|---|
| Epidural-Related Fever | Intrapartum fever (≥38 °C), Absence of other clinical findings of intrauterine inflammation (abdominal pain, maternal/fetal tachycardia, etc.)[2][1] |
| Appendicitis | Presents with abdominal pain that begins around the umbilicus, then migrates to the right lower quadrant (relatively rare but also possible at right upper quadrant), nausea vomiting, abdominal guarding, deep tenderness at MBburney’s point, dysuria[3] |
| Pneumonia | Presents with fever, productive cough, pleuritic chest pain, dyspnea, rigor, perspiration, and findings on auscultation such as inspiratory rales localized to the affected area |
| Influenza | Presents with acute fever, headache, cough, rigor, perspiration, myalgias, and malaise[4] |
| Pyelonephritis | Presents with fever, chills, malaise, dysuria, urinary urgency, polyuria, nausea, flank pain[5] |
| Others | Thrombophlebitis, placental abruption, colitis, connective tissue disorders, and round ligament pain can produce abdominal pain that may be confused with chorioamnionitis. However, the absence of fever indicates these conditions rather than chorioamnionitis.[1] |
References
- ↑ 1.0 1.1 1.2 Tita AT, Andrews WW (June 2010). “Diagnosis and management of clinical chorioamnionitis”. Clin Perinatol. 37 (2): 339–54. doi:10.1016/j.clp.2010.02.003. PMC 3008318. PMID 20569811.
- ↑ Jansen S, Lopriore E, Naaktgeboren C, Sueters M, Limpens J, van Leeuwen E, Bekker V (2020). “Epidural-Related Fever and Maternal and Neonatal Morbidity: A Systematic Review and Meta-Analysis”. Neonatology. 117 (3): 259–270. doi:10.1159/000504805. PMID 31991422.
- ↑ Franca Neto AH, Amorim MM, Nóbrega BM (2015). “Acute appendicitis in pregnancy: literature review”. Rev Assoc Med Bras (1992). 61 (2): 170–7. doi:10.1590/1806-9282.61.02.170. PMID 26107368.
- ↑ Gaitonde DY, Moore FC, Morgan MK (December 2019). “Influenza: Diagnosis and Treatment”. Am Fam Physician. 100 (12): 751–758. PMID 31845781.
- ↑ Johnson JR, Russo TA (January 2018). “Acute Pyelonephritis in Adults”. N Engl J Med. 378 (1): 48–59. doi:10.1056/nejmcp1702758. PMID 29298155.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
The prevalence of chorioamnionitis was estimated to be approximately 4,000 cases per 100,000 individuals worldwide. Chorioamnionitis more commonly affects individuals < 18 years of age. Gestational age is also a strong predictor of chorioamnionitis with increased prevalence in people who delivered between 21 and 24 weeks of gestation. Male infants are more commonly affected than females. Chorioamnionitis usually affects individuals of Hispanics and Asian/Pacific Islanders.
Epidemiology and Demographics
Prevelance
- Worldwide, the prevalence of chorioamnionitis is approximately 4,000 per 100,000 persons.[1]
- In developed countries, the prevalence of chorioamnionitis is 970 per 100,000 persons.[2]
Age
- Chorioamnionitis is more commonly seen in patients < 18 years of age.[2]
Gestational Age
- The prevalence of chorioamnionitis decreases with gestational age until 37-40 weeks of gestation, then slightly increases again.
Gender
Race
- Chorioamnionitis usually affects individuals of non-White races. White individuals are less likely to develop chorioamnionitis.[2]
- Chorioamnionitis is more prevalent in Hispanics and Asian/Pacific Islanders.
- Although individuals of the Black race usually less affected than Hispanics and Asian/Pacific Islanders, the prevalence of chorioamnionitis is higher in individuals of the black race than whites.
References
- ↑ Fowler JR, Simon LV. PMID 30335284. Missing or empty
|title=(help) - ↑ 2.0 2.1 2.2 2.3 Malloy MH (August 2014). “Chorioamnionitis: epidemiology of newborn management and outcome United States 2008”. J Perinatol. 34 (8): 611–5. doi:10.1038/jp.2014.81. PMID 24786381.
- ↑ Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM (October 2015). “Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance”. Am J Obstet Gynecol. 213 (4 Suppl): S29–52. doi:10.1016/j.ajog.2015.08.040. PMC 4774647. PMID 26428501.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2] ; Abdurahman Khalil, M.D. [3]
Overview
Common risk factors in the development of chorioamnionitis include preterm premature rupture of membranes (PPROM), prematurity, nulliparity, prolonged labor and rupture of membranes, multiple digital vaginal examinations, meconium stained amniotic fluid, internal fetal monitoring, epidural anesthesia, immunocompromised state, maternal behavioral conditions, and infections.
Risk Factors
Common risk factors in the development of chorioamnionitis include:[1][2]
- Preterm premature rupture of membranes (PPROM)
- Prolonged rupture of membranes
- Prolonged labor
- Prolonged second stage
- Intrapartum Hypertension
- Prematurity
- Postterm Pregnancy
- Nulliparity
- Cesarean section due either to fetal heart rate decelerations or dystocia
- Internal fetal monitoring
- Multiple digital vaginal examinations
- Epidural anesthesia
- Meconium stained amniotic fluid
- Immunocompromised state
- Behavioral conditions
- Infections
- Maternal genital tract colonization with group B Streptococcus
- Sexually transmitted diseases (STDs)
- Maternal genital colonization with ureoplasma
References
- ↑ Tita AT, Andrews WW (June 2010). “Diagnosis and management of clinical chorioamnionitis”. Clin Perinatol. 37 (2): 339–54. doi:10.1016/j.clp.2010.02.003. PMC 3008318. PMID 20569811.
- ↑ Alexander JM, McIntire DM, Leveno KJ (August 1999). “Chorioamnionitis and the prognosis for term infants”. Obstet Gynecol. 94 (2): 274–8. doi:10.1016/s0029-7844(99)00256-2. PMID 10432142.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]
References
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
Clinical findings associated with chorioamnionitis include maternal fever, uterine tenderness, purulent/foul-smelling amniotic fluid, maternal/fetal tachycardia. Common fetal complications of chorioamnionitis include preterm birth, neonatal sepsis, neurologic complications, respiratory complications. Common maternal complications of chorioamnionitis include maternal sepsis, infections, and labor-related complications (e.g., cesarean section, postpartum hemorrhage, etc.)
Natural History, Complications, and Prognosis
Natural History
The symptoms of chorioamnionitis usually develop during the pregnancy, and start with symptoms such as maternal fever, uterine tenderness, purulent/foul-smelling amniotic fluid, maternal/fetal tachycardia.[1]
Complications
Fetal complications that can develop as a result of chorioamnionitis are:[2][3]
- Preterm birth
- Retinopathy of prematurity
- Neonatal sepsis
- Neonatal death
- Neurologic complications
- Respiratory complications
Maternal complications that can develop as a result of chorioamnionitis are:[3][1]
- Maternal sepsis
- Infections
- Severe pelvic infections and abscess
- Wound infections
- Endomyometritis
- Labor-related complications
Prognosis
The presence of cesarean delivery for dystocia, prolonged labor times (≥ 10 h), or administration of oxytocin during labor are associated with a particularly poor prognosis among infants exposed to chorioamnionitis.[4]
References
- ↑ 1.0 1.1 Tita AT, Andrews WW (June 2010). “Diagnosis and management of clinical chorioamnionitis”. Clin Perinatol. 37 (2): 339–54. doi:10.1016/j.clp.2010.02.003. PMC 3008318. PMID 20569811.
- ↑ Ericson JE, Laughon MM (March 2015). “Chorioamnionitis: implications for the neonate”. Clin Perinatol. 42 (1): 155–65, ix. doi:10.1016/j.clp.2014.10.011. PMC 4331454. PMID 25678002.
- ↑ 3.0 3.1 Fowler JR, Simon LV. PMID 30335284. Missing or empty
|title=(help) - ↑ Alexander JM, McIntire DM, Leveno KJ (August 1999). “Chorioamnionitis and the prognosis for term infants”. Obstet Gynecol. 94 (2): 274–8. doi:10.1016/s0029-7844(99)00256-2. PMID 10432142.
Diagnosis
Diagnosis
Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-ray Findings | Echocardiography and Ultrasound | CT Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
